Kyras Therapeutics
-
2015
Company Description
Kyras Therapeutics is a biotech company
Kyras Therapeutics is a biotech company. According to data from the National Cancer Institute, more than 30 percent of all human cancers are driven by mutations in RAS genes, including 95% of pancreatic, 45% of colorectal, and 35% of lung cancers, among many others.
-
Manufacturer:
Science and Engineering -
Formed:
2015 -
Founders:
Brent Stockwell -
Company Website:
-
Company E-mail:
-
Company Address:
430 East 29th Street,, Suite 1005New York, NYUnited States -
CEO:
- Brent Stockwell
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits